Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eugenio Tremante"'
Autor:
Aikaterini Detoraki, Eugenio Tremante, Remo Poto, Emanuela Morelli, Giuseppe Quaremba, Francescopaolo Granata, Antonio Romano, Ilaria Mormile, Francesca Wanda Rossi, Amato de Paulis, Giuseppe Spadaro
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, small vessel, necrotizing vasculitis. The disease is mainly characterized by hypereosinophilia and asthma with frequent sinonasal involvement, although multiple organs can be af
Externí odkaz:
https://doaj.org/article/820e206d876943ab9391874792941255
Autor:
Aikaterini Detoraki, Eugenio Tremante, Maria D’Amato, Cecilia Calabrese, Claudia Casella, Mauro Maniscalco, Remo Poto, Raffaele Brancaccio, Matilde Boccia, Maria Martino, Clara Imperatore, Giuseppe Spadaro
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: Severe eosinophilic asthma is frequently associated to chronic rhinosinusitis and nasal polyposis (CRSwNP) that contribute to poor asthma control. Mepolizumab is an anti-IL-5 monoclonal antibody, approved for the treatment of severe eosin
Externí odkaz:
https://doaj.org/article/514c1273d7b74f2f81d4794065fed241
Autor:
Veronica Seccia, Maria D’Amato, Giulia Scioscia, Diego Bagnasco, Fabiano Di Marco, Gianluca Fadda, Francesco Menzella, Ernesto Pasquini, Girolamo Pelaia, Eugenio Tremante, Eugenio De Corso, Matteo Bonini
Publikováno v:
Journal of Personalized Medicine. 12:1096
Chronic rhinosinusitis (CRS) is one of the most frequent comorbidities associated with asthma and it contributes to an amplified global disease burden in asthmatics. CRS prevalence is much higher in asthmatic patients compared to the general populati
Autor:
Antonio Romano, Remo Poto, Giuseppe Quaremba, Ilaria Mormile, Emanuela Morelli, Francesca Wanda Rossi, Giuseppe Spadaro, Amato de Paulis, Eugenio Tremante, Francescopaolo Granata, Aikaterini Detoraki
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Respiratory Research
Respiratory Research
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, small vessel, necrotizing vasculitis. The disease is mainly characterized by hypereosinophilia and asthma with frequent sinonasal involvement, although multiple organs can be affected, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d61a797540f2b1d8f0e06bae466f90ff
http://hdl.handle.net/11386/4768425
http://hdl.handle.net/11386/4768425
Autor:
Marianna Maffei, Corrado Pelaia, Rosalba Maffucci, Salvatore Abbadessa, Martina Flora, Cecilia Calabrese, Francesco Perna, Mauro Maniscalco, Eugenio Tremante, Federica Garziano, Mariano Mollica
Background: Several studies have shown an association between severe asthma and serum immunoglobulins E (IgE) against Staphylococcus aureus enterotoxins (SEs). SEs—the prototypes being types A (SEA), B (SEB) and toxic shock syndrome toxin 1 (TSST-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee2347970a8f5bccf1e4c393b1099e2
http://hdl.handle.net/11591/458972
http://hdl.handle.net/11591/458972
Autor:
Aikaterini Detoraki, Giuseppe Quaremba, Raffaella Giacco, Cecilia Calabrese, Matilde Boccia, Mauro Maniscalco, Eugenio Tremante, Giuseppe Spadaro, Maria D'Amato, Remo Poto
Publikováno v:
Airway pharmacology and treatment.
Background: Eosinophilic severe asthma is frequently associated to chronic rhinosinusitis and nasal polyposis (CRSwNP), which contributes to the poor asthma control in these patients. Mepolizumab is an anti-IL-5 monoclonal antibody, which has been re
Autor:
Cecilia Calabrese, Andrea Bianco, Adriano Costigliola, Carlo Antonio Leone, Elena Merola, Marianna Maffei, Francesco Perna, Vittorio Simeon, Eugenio Tremante
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
International Journal of COPD, Vol Volume 13, Pp 2025-2032 (2018)
International Journal of COPD, Vol Volume 13, Pp 2025-2032 (2018)
Background: A high percentage of patients with COPD report chronic nasal symptoms. The study aims to evaluate the clinical impact of a 2-month treatment with inhaled nasal budesonide (100 µg per nostril twice daily) in patients affected by COPD with